We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

101 hedge funds and large institutions have $1.31B invested in Bicycle Therapeutics in 2021 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 12

122% more capital invested

Capital invested by funds: $591M → $1.31B (+$721M)

100% more funds holding in top 10

Funds holding in top 10: 4 → 8 (+4)

69% more call options, than puts

Call options by funds: $2.63M | Put options by funds: $1.56M

46% more funds holding

Funds holding: 69 → 101 (+32)

17.65% more ownership

Funds ownership: 55.71% → 73.35% (+18%)

4% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 25

Holders
101
Holders Change
+32
Holders Change %
+46.38%
% of All Funds
1.55%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.12%
New
45
Increased
26
Reduced
25
Closed
12
Calls
$2.63M
Puts
$1.56M
Net Calls
+$1.07M
Net Calls Change
-$5.01M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$55.1M
2
RI
RTW Investments
New York
+$48M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$43.9M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$31.5M
5
Victory Capital Management
Victory Capital Management
Texas
+$22.9M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$33.4M
2
SHI
SV Health Investors
Massachusetts
-$28.6M
3
AVA
Atlas Venture Advisors
Massachusetts
-$12.8M
4
SC
Samlyn Capital
New York
-$8.04M
5
GTC
Ghost Tree Capital
New York
-$4.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCI
1
Ridgeback Capital Investments
Florida
$132M +$119M +2,164,801 New
TCM
2
Tybourne Capital Management
Hong Kong
$125M +$5.29M +95,843 +5%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$103M -$2.63M -47,596 -3%
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$95.7M -$2.33M -42,269 -3%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$88.9M +$55.1M +999,253 +216%
EAM
6
Eventide Asset Management
Massachusetts
$76.9M +$5.52M +100,000 +9%
DTC
7
Deep Track Capital
Connecticut
$67M +$60.7M +1,100,000 New
FLAM
8
First Light Asset Management
Minnesota
$60.9M +$14.8M +268,052 +37%
SHI
9
SV Health Investors
Massachusetts
$55.9M -$28.6M -518,302 -36%
LGM
10
Logos Global Management
California
$53M -$33.4M -605,000 -41%
RI
11
RTW Investments
New York
$52.9M +$48M +869,271 New
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$48.5M +$43.9M +796,014 New
IC
13
Ikarian Capital
Texas
$37.3M +$4.78M +86,626 +16%
Loomis, Sayles & Company
14
Loomis, Sayles & Company
Massachusetts
$34.7M +$31.5M +570,047 New
Victory Capital Management
15
Victory Capital Management
Texas
$34.6M +$22.9M +414,845 +270%
FM
16
Frazier Management
Washington
$33.8M +$6.2M +112,360 +25%
SC
17
Samlyn Capital
New York
$18.8M -$8.04M -145,766 -32%
DCM
18
Driehaus Capital Management
Illinois
$16.3M +$14.7M +267,032 New
BlackRock
19
BlackRock
New York
$12.4M +$11.3M +203,995 New
GPP
20
Great Point Partners
Connecticut
$12.2M +$11M +200,000 New
Acadian Asset Management
21
Acadian Asset Management
Massachusetts
$10.9M +$8.68M +157,365 +743%
ACM
22
Altium Capital Management
New York
$10.5M +$4.41M +80,000 +87%
Verition Fund Management
23
Verition Fund Management
Connecticut
$10M -$803K -14,546 -8%
Millennium Management
24
Millennium Management
New York
$9.3M +$8.43M +152,732 New
Two Sigma Investments
25
Two Sigma Investments
New York
$9.21M +$3.26M +59,169 +64%
1
2 3 4 5

BCYC Hedge Fund Activity: Q4 2021 in Review

101 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q4 2021, worth a combined $1.31B — up 122% from $591M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new BCYC positions and 12 closed out — a net gain of 33 holders — while 26 added to existing stakes and 25 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $55.1M. The largest seller was Logos Global Management, cutting an estimated $33.4M.

  • 101 institutional investors held Bicycle Therapeutics (BCYC) as of Q4 2021, up from 69 in Q3 2021.
  • Funds reported $1.31B of Bicycle Therapeutics stock for Q4 2021, up 122% quarter-over-quarter.
  • 45 funds opened new Bicycle Therapeutics positions in Q4 2021 and 12 closed out, a net change of +33 holders.
  • The largest Bicycle Therapeutics buyer in Q4 2021 was Fidelity Investments, an estimated $55.1M added.
  • The largest Bicycle Therapeutics seller in Q4 2021 was Logos Global Management, an estimated $33.4M sold.

Based on aggregated 13F filings for Q4 2021.